Literature DB >> 24892517

Chlorambucil (nitrogen mustard) induced impairment of early vascular endothelial cell migration - effects of α-linolenic acid and N-acetylcysteine.

Dirk Steinritz1, Annette Schmidt2, Thilo Simons3, Marwa Ibrahim4, Christian Morguet5, Frank Balszuweit6, Horst Thiermann7, Kai Kehe8, Wilhelm Bloch9, Birgit Bölck10.   

Abstract

Alkylating agents (e.g. sulfur and nitrogen mustards) cause a variety of cell and tissue damage including wound healing disorder. Migration of endothelial cells is of utmost importance for effective wound healing. In this study we investigated the effects of chlorambucil (a nitrogen mustard) on early endothelial cells (EEC) with special focus on cell migration. Chlorambucil significantly inhibited migration of EEC in Boyden chamber and wound healing experiments. Cell migration is linked to cytoskeletal organization. We therefore investigated the distribution pattern of the Golgi apparatus as a marker of cell polarity. Cells are polarized under control conditions, whereas chlorambucil caused an encircling perinuclear position of the Golgi apparatus, indicating non-polarized cells. ROS are discussed to be involved in the pathophysiology of alkylating substances and are linked to cell migration and cell polarity. Therefore we investigated the influence of ROS-scavengers (α-linolenic acid (ALA) and N-acetylcysteine (NAC)) on the impaired EEC migration. Both substances, in particular ALA, improved EEC migration. Notably ALA restored cell polarity. Remarkably, investigations of ROS and RNS biomarkers (8-isoprostane and nitrotyrosine) did not reveal a significant increase after chlorambucil exposure when assessed 24h post exposure. A distinct breakdown of mitochondrial membrane potential (measured by TMRM) that recovered under ALA treatment was observed. In conclusion our results provide compelling evidence that the alkylating agent chlorambucil dramatically impairs directed cellular migration, which is accompanied by perturbations of cell polarity and mitochondrial membrane potential. ALA treatment was able to reconstitute cell polarity and to stabilize mitochondrial potential resulting in improved cell migration.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chlorambucil; Endothelial cell; Migration; Mitochondrial membrane potential; Nitrogen mustard; ROS-scavenger

Mesh:

Substances:

Year:  2014        PMID: 24892517     DOI: 10.1016/j.cbi.2014.05.015

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  5 in total

1.  Assessment of Endothelial Cell Migration After Exposure to Toxic Chemicals.

Authors:  Dirk Steinritz; Annette Schmidt; Frank Balszuweit; Horst Thiermann; Marwa Ibrahim; Birgit Bölck; Wilhelm Bloch
Journal:  J Vis Exp       Date:  2015-07-10       Impact factor: 1.355

2.  A microbiome and metabolomic signature of phases of cutaneous healing identified by profiling sequential acute wounds of human skin: An exploratory study.

Authors:  Mohammed Ashrafi; Yun Xu; Howbeer Muhamadali; Iain White; Maxim Wilkinson; Katherine Hollywood; Mohamed Baguneid; Royston Goodacre; Ardeshir Bayat
Journal:  PLoS One       Date:  2020-02-27       Impact factor: 3.240

3.  Preparation and Study of Solid Lipid Nanoparticles Based on Curcumin, Resveratrol and Capsaicin Containing Linolenic Acid.

Authors:  Roberta Cassano; Simona Serini; Federica Curcio; Sonia Trombino; Gabriella Calviello
Journal:  Pharmaceutics       Date:  2022-07-30       Impact factor: 6.525

4.  Transient Receptor Potential Channel A1 (TRPA1) Regulates Sulfur Mustard-Induced Expression of Heat Shock 70 kDa Protein 6 (HSPA6) In Vitro.

Authors:  Robin Lüling; Harald John; Thomas Gudermann; Horst Thiermann; Harald Mückter; Tanja Popp; Dirk Steinritz
Journal:  Cells       Date:  2018-08-31       Impact factor: 6.600

Review 5.  N-Acetylcysteine as a treatment for sulphur mustard poisoning.

Authors:  Thomas W Sawyer
Journal:  Free Radic Biol Med       Date:  2020-09-25       Impact factor: 7.376

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.